Drug intelligence / Profile preview

Yizhi Annao Granule

Development stage
Unknown
Lead developer
Beijing Jingshi Naoli Technology
Administration
Oral
01

Overview

Yizhi Annao Granule (益智安脑颗粒) is a Class 1.1 Traditional Chinese Medicine (TCM) innovative drug developed by Beijing Jingshi Naoli Technology for the treatment and prevention of cognitive disorders, including vascular cognitive impairment, vascular dementia, and Alzheimer's disease (senile dementia). Formulated based on TCM disease-collaterals theory, the drug is designed to improve cognitive function and protect brain health. The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine has sponsored clinical trials evaluating Yizhi Annao Granule in patients with vascular cognitive impairment after stroke, comparing its efficacy and safety to donepezil and utilizing brain imaging biomarkers such as resting-state fMRI and diffusion tensor imaging. In 2024, Beijing Jingshi Naoli Technology received clinical trial implied permission (IND approval) in China for Yizhi Annao Granule for the treatment of vascular dementia.

Other names
Yizhi Annao Granules益智安脑颗粒

Beyond the preview

Go deeper on Yizhi Annao Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yizhi Annao Granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call